Sign in
8-K

Current Report

CytomX Therapeutics, Inc. Filed Acc 0001564590-16-014110

Results of operations · Executive or director change

  • Item 2.02 Results of operations and financial condition
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading ctmx-8k_20160301.htm…